Corrigendum to “Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury”
Joint Authors
Bhatia, Jagriti
Ojha, Shreesh
Goyal, Sameer N.
Suchal, Kapil
Malik, Salma
Gamad, Nanda
Malhotra, Rajiv Kumar
Chaudhary, Uma
Arya, Dharmveer S.
Source
Oxidative Medicine and Cellular Longevity
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-06-18
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
In the article titled “Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury” [1], it was identified that the beta-actin panels in Figures 4(a), 4(b), and 4(c) were identical.
With the agreement of the editor, a revised version of Figure 4 is being provided with the data from a repeat of the experiment.
The authors apologize for this error in the original publication.
The corrected version of figure 4 is shown as Figure 1.
American Psychological Association (APA)
Suchal, Kapil& Malik, Salma& Gamad, Nanda& Malhotra, Rajiv Kumar& Goyal, Sameer N.& Chaudhary, Uma…[et al.]. 2020. Corrigendum to “Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury”. Oxidative Medicine and Cellular Longevity،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1204536
Modern Language Association (MLA)
Suchal, Kapil…[et al.]. Corrigendum to “Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury”. Oxidative Medicine and Cellular Longevity No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1204536
American Medical Association (AMA)
Suchal, Kapil& Malik, Salma& Gamad, Nanda& Malhotra, Rajiv Kumar& Goyal, Sameer N.& Chaudhary, Uma…[et al.]. Corrigendum to “Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury”. Oxidative Medicine and Cellular Longevity. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1204536
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1204536